Previous studies also demonstrated that the administration of low-dose tamoxifen (1–5 mg/day) had biological effects on breast cancer in terms of the Ki-67 index and lower endometrial cell proliferation [39, 40]. This evidence concerns the gene MKI67 and breast cancer.